Literature DB >> 12909451

Langerhans-cell histiocytosis: neoplasia or unbridled inflammation?

Bengt Fadeel, Jan-Inge Henter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909451     DOI: 10.1016/s1471-4906(03)00171-6

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


× No keyword cloud information.
  5 in total

1.  Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Authors:  Tricia L Peters; Kenneth L McClain; Carl E Allen
Journal:  Mol Ther       Date:  2011-06-07       Impact factor: 11.454

Review 2.  Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Authors:  Milen Minkov
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

3.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

4.  Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions.

Authors:  Carl E Allen; Kenneth L McClain
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

Review 5.  Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.

Authors:  Caroline Hutter; Milen Minkov
Journal:  Immunotargets Ther       Date:  2016-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.